Abstract: A spray-dried component which is in the form of a free-flowing particle with high chelant activity comprising: i) at least 50%, preferably at leaxt 60%, by weight, of a chelant; ii) from 1% to 25%, preferably from 5% to 10%, by weight of an alkali metal or alkaline earth metal sulfate; and iii) preferably less than 10% by weight of free moisture.

Abstract: Mild detergent compositions which exhibit good cleaning performance comprise detergent surfactants and small amounts of protease. A preferred embodiment additionally contains suds boosters and divalent ions.

Abstract: Detergent compositions comprise a surfactant selected from anionic, nonionic, cationic, amphoteric and zwitterionic detergent-active compounds and mixtures thereof; a detergency builder comprising zeolite P having a silicon to aluminium ratio not greater than 1.33; from 0.05% to 0.3%, by weight of the composition, anionic N-bonded stilbene optical brightener; and one or more additional components selected from manganese phthalocyaninetetrasulphonate and polymers selected from polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinylpyrrolidones, polyvinyloxazolidones, polyvinylimidazoles and mixtures thereof.

Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition contains N-chlorophenylcarbamates and N-chlorophenylthiocarbamates along with a chemotherapeutic agent and optionally a potentiator. A composition for treating viral infections in animals or humans comprising a safe and effective amount of N-chlorophenylcarbamates and the N-chlorophenylthiocarbamates and a potentiator is also disclosed.

Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals and can be used to treat viral infections that comprises a fungicide in combination with chemotherapeutic agents is disclosed. The particular fungicide used is a benzimidazole derivative. Potentiators can also be included in the composition.

Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition is also effective against viruses. The composition contains N-phosphonoglycine derivatives which are systemic herbicides.

Abstract: An emulsified detergent composition is provided. The detergent composition comprises from about 0.1% to about 70%, by weight of the detergent composition, of a detersive surfactant wherein at least from about 70% to about 90%, by weight of the detersive surfactant, is a nonionic surfactant. The detergent composition also includes an electrolyte, in an amount sufficient to render the cloud point of the detergent composition to be less than about 20.degree. C., and water. The detersive surfactant and the water are in two phases in a weight ratio of about 1:10 to about 10:1 in the detergent composition. Superior cleaning and stain removal results because the emulsified detergent composition provides separation of the water and surfactant phases in a low water wash system over a broad temperature range and allows for cleaning below the cloud point of the surfactant system.

Abstract: The present invention is a liquid detergent composition containing anionic surfactant and cellulase. Said composition further comprises hydrophobic amines as cellulase stabilizers.

Abstract: A granular detergent composition having a density from 550 to 950 g/liter, said detergent composition comprisingi) a polymeric dye transfer inhibiting agentii) a protease having an isoelectric point below 10iii) a surfactant system which is free of alkylbenzene sulfonate surfactant.

Abstract: The present invention relates to rinse-added laundry additive compositions having a color care agent and to methods for using the compositions. The laundry additive composition comprises from about 0.1% to about 50% of by weight of the composition of a color care agent having the formula:(R.sub.1)(R.sub.2)N(CX.sub.2).sub.n N(R.sub.3)(R.sub.4)wherein X is selected from the group consisting of hydrogen, linear or branched; substituted or unsubstituted alkyl having from 1-10 carbons atoms and substituted or unsubstituted aryl having at least 6 carbon atoms; n is an integer from 1 to 6; R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are independently selected from the group consisting of alkyl; aryl; alkaryl; arylalk; hydroxyalkyl; polyhydroxyalkyl; polyalkylether having the formula --((CH.sub.2).sub.y O).sub.z R.sub.7 where R.sub.

Abstract: Absorbent articles such as diapers, incontinent briefs, training pants, diaper holders and liners, feminine hygiene garments, and the like designed to provide sustained dynamic fit about the wearer during use as well as to improve the containment of body exudates and wearer comfort/mobility. Such an absorbent article has an absorbent core preferably designed to fit within the low motion zone of the wearer so that dynamic forces imparted by movements of the wearer on the absorbent core are minimized. the absorbent article is also provided with a closure system for anchoring the absorbent article on the wearer to sustain the dynamic fit of the absorbent article throughout wearing. The closure system is designed so that a plane of tension is formed at least about the front waist portion of the article to preclude rollover of the front waist portion.

Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals that comprises a material is disclosed. The particular material used is a 1H-1,2,4-triazole derivative. These compounds can also be used to treat viral infections.

Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition contains N-phosphonoglycine derivatives which are systemic herbicides in combination with chemotherapeutic agents for treatment of cancers and tumors. N-phosphonoglycine derivatives can be used to treat viral infections, particularly herpes infections. Optionally potentiators can be included.

Abstract: The present invention concerns a foam having a bulk density of less than 250 g/l; the foam having a stability in air of at least 15 seconds (and preferably at least 30 seconds), the stability being defined as the time for the foam to collapse to half its volume when measured in a 111 mm internal diameter and 62 mm internal height glass beaker; wherein the foam has a stability on water at 20.degree. C. of less than 2 hours, the stability on water being defined as the time taken for a 150 ml foam mass on the surface of 450 ml distilled water in a 111 mm internal diameter and 62 mm internal height glass beaker, to collapse to reveal a 2 cm diameter area of the water surface which is substantially free from foam.

Abstract: The present invention relates to dryer-activated laundry additive compositions and products having a color care agent and to methods for using the compositions and products. The dryer-activated laundry additive composition comprises from about 0.1% to about 50% of by weight of the composition of a color care agent having the formula:(R.sub.1)(R.sub.2)N(CX.sub.2).sub.n N(R.sub.3)(R.sub.4)wherein X is selected from the group consisting of hydrogen, linear or branched; substituted or unsubstituted alkyl having from 1-10 carbons atoms and substituted or unsubstituted aryl having at least 6 carbon atoms; n is an integer from 1 to 6; R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are independently selected from the group consisting of hydrogen; alkyl; aryl; alkaryl; arylalk; hydroxyalkyl; polyhydroxyalkyl; polyalkylether having the formula --((CH.sub.2).sub.y O).sub.z R.sub.7 where R.sub.

Abstract: A detergent composition containing in combination(a) a detergent builder system containing a carboxylate or polycarboxylate builder and having a major proportion by weight of non-carbonate builder compound;(b) an organo diphosphonic acid or its salts or complexes or any mixture thereof; and(c) an organic polymer containing acrylic acid or its salts, having an average molecular weight of less than 15,000.

Abstract: A beverage such as a dilute juice or tea beverage having a stable flavor/cloud emulsion that contains from about 0.005 to about 0.015% xanthan gum, from about 100 ppm to about 1000 ppm of a preservative selected from sorbic acid, benzoic acid, alkali metal salts thereof and mixtures thereof, from about 300 ppm to about 3000 ppm of a food grade water soluble polyphosphate, and from about 60 to about 99% by weight of added water having from 0 ppm to about 180 ppm of hardness.

Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals that comprises a material is disclosed. The particular material used is a 1H-1,2,4-triazole derivative. These compounds can also be used to treat viral infections.

Abstract: A smooth, high density tissue. The tissue has a relatively low caliper, yet maintains visually discernible machine direction micropeaks at a suitable micropeak frequency.

Abstract: Fabric softening compositions comprising fabric softening active(s), cellulase and an antioxidant effective amount of free radical scavenging antioxidant material and/or chelant.